PAPA test

The Papa test, also known as the Papanicolaou test, is a gynecological procedure used for screening cervical cancer. The aim of the test is to identify precancerous changes or abnormal cells on the cervix that may indicate a risk of developing cancer.

How is it performed?

The test is usually conducted during a routine gynecological examination. The doctor inserts a speculum into the vagina to visualize the cervix and then uses a small brush or spatula to gently scrape cells from the surface and from the cervical canal. The collected sample is placed on a slide or in a special liquid for cytological analysis.

What does the test detect?

The test can detect abnormal cells that may indicate precancerous changes or cervical cancer. It can also detect changes caused by the human papillomavirus (HPV), which is the main cause of cervical cancer. If abnormal cells are found, the doctor may recommend additional examinations, such as a colposcopy, or retesting after a certain period.

When and how often to test?

Recommendations for the frequency of the Papa test vary depending on age, history of test results, and other health risk factors. Women typically start regular testing at age 21 or within three years of the onset of sexual activity. Regular testing can detect abnormal cells early before they develop into cancer, allowing for early intervention and treatment. The Papa test is crucial in reducing the incidence and mortality of cervical cancer.